Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
Clinical trial NCT03897127 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03897127
- Sponsor
- University of Ulm
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2027-06-01
- Enrollment
- 882
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.